Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Short term Debt (2016 - 2025)

Haemonetics (HAE) has 16 years of Short term Debt data on record, last reported at $304.7 million in Q4 2025.

  • For Q4 2025, Short term Debt rose 5904.85% year-over-year to $304.7 million; the TTM value through Dec 2025 reached $304.7 million, up 5904.85%, while the annual FY2025 figure was $303.6 million, 2867.62% up from the prior year.
  • Short term Debt reached $304.7 million in Q4 2025 per HAE's latest filing, roughly flat from $304.3 million in the prior quarter.
  • Across five years, Short term Debt topped out at $304.7 million in Q4 2025 and bottomed at $5.1 million in Q4 2024.
  • Average Short term Debt over 5 years is $92.3 million, with a median of $15.4 million recorded in 2021.
  • Peak YoY movement for Short term Debt: crashed 94.5% in 2023, then soared 5904.85% in 2025.
  • A 5-year view of Short term Debt shows it stood at $82.7 million in 2021, then tumbled by 87.97% to $9.9 million in 2022, then skyrocketed by 38.06% to $13.7 million in 2023, then crashed by 63.05% to $5.1 million in 2024, then skyrocketed by 5904.85% to $304.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Short term Debt were $304.7 million in Q4 2025, $304.3 million in Q3 2025, and $303.9 million in Q2 2025.